BioHarvest Sciences Inc. Common Stock BHST
Set alert
As of Nov 2, 10:06 AM ET
- YTD
- -68.40%
- 1 year
- -81.68%
- Open
- 1.63
- Prev close
- 1.65
- Mkt cap
- 37.18M
- Vol
- 1.58K
- Avg vol
- 38.71K
- EPS
- -0.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.60
- High
- 1.64
- Forward P/E
- 0.00
- Beta
- 1.49
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.70
- 200-d avg
- 4.12
- 1y target
- 14.67
News
4 days ago newsfilecorp.com
BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in…
2 weeks ago proactiveinvestors.com
BioHarvest takes second plant-cell asset to commercial readiness
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Tuesday that Olive Cell, an olive-derived plant-cell ingredient, is ready for commercial licensing, the second product from its Botanical…
-
2 weeks ago benzinga.com
BioHarvest Sciences' Proprietary Olive Cell Composition Attains Commercial Readiness, Now Available For Licensing And Commercialization
Botanical Synthesis™-developed asset has now completed development, commercial-scale manufacturing and the applicable self-affirmed GRAS process and is ready for production at BioHarvest's GMP…
2 weeks ago newsfilecorp.com
BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity
Botanical Synthesis™-developed asset has now completed development, commercial-scale manufacturing and the applicable self-affirmed GRAS process and is ready for production at BioHarvest's GMP…
3 weeks ago proactiveinvestors.com
BioHarvest says its platform can produce target sweetener in Tate & Lyle program
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Thursday its Botanical Synthesis platform can produce the next-generation sweetener targeted in its joint development program with Tate & Lyle.…
3 weeks ago newsfilecorp.com
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
Progress demonstrates that BioHarvest's Botanical Synthesis(TM) platform is capable of producing the targeted next-generation sweetening solution Vancouver, British Columbia and Rehovot,…
1 month ago proactiveinvestors.com
BioHarvest Sciences launches buyback of up to 5% of shares
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said Tuesday its board has authorized a share repurchase program covering up to 5% of its outstanding common shares. The company, which develops and…
-
1 month ago benzinga.com
BioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding Common Shares
BioHarvest Sciences Inc. (NASDAQ:BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for
1 month ago newsfilecorp.com
BioHarvest Sciences Announces Share Repurchase Program
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical…
1 month ago newsfilecorp.com
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical Synthesis Format expansion shows how BioHarvest can help CDMO…
1 month ago newsfilecorp.com
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology…
1 month ago proactiveinvestors.com
Fiinu shares jump over 6% as Conister Bank platform enters production
Fiinu (AIM: BANK), the UK fintech group, rose over 6% to 4p on Friday after its Plugin Overdraft platform moved into production ahead of a planned year-end...
2 months ago proactiveinvestors.com
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to pursue a dual listing of its ordinary shares on the Tel Aviv Stock Exchange (TASE), with trading expected to begin on September 8, 2026. The…
2 months ago newsfilecorp.com
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable…
-
2 months ago benzinga.com
Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $12 to $5.
-
2 months ago benzinga.com
Roth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8
Roth Capital analyst Sean McGowan maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $10 to $8.
-
2 months ago benzinga.com
Conference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
BioHarvest Sciences (NASDAQ:BHST) lowers FY2026 sales outlook from $42.000 million-$48.000 million to $37.000 million-$40.000 million vs $42.914 million estimate.
2 months ago seekingalpha.com
BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
BioHarvest Sciences Q2 Earnings Call Highlights
BioHarvest Sciences NASDAQ: BHST reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within…
2 months ago proactiveinvestors.com
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) reported higher second-quarter revenue as the plant-based molecule developer shifted spending toward manufacturing capacity. Revenue for the quarter…
2 months ago zacks.com
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.15 per share a year ago.
-
2 months ago benzinga.com
BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
BioHarvest Sciences (NASDAQ:BHST) stated that full-year 2026 revenue guidance for its CDMO business has been narrowed to $4 million-$5 million, from $4 million-$6 million previously, while revenue…
2 months ago newsfilecorp.com
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance, that BioHarvest expects to drive profitable growth…
-
2 months ago benzinga.com
BioHarvest Sciences Enters Agreement For A Rare, Endangered Fragrance Plant Cell Culture With A UAE-Based Customer; Sees $20M-$30M In 2027-28 Sales
This particular scent is widely regarded as one of the most valuable fragrance raw materials in the world, with premium grades commanding prices exceeding tens of thousands of U.S. dollars per…
2 months ago newsfilecorp.com
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenue Positions BioHarvest in sustainable rare luxury fragrance manufacturing BioHarvest to target additional…
3 months ago defenseworld.net
Head-To-Head Analysis: BioHarvest Sciences (NASDAQ:BHST) versus Nu Skin Enterprises (NYSE:NUS)
Nu Skin Enterprises (NYSE: NUS - Get Free Report) and BioHarvest Sciences (NASDAQ: BHST - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will…
3 months ago newsfilecorp.com
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable…
-
3 months ago benzinga.com
BioHarvest Sciences Receives $1.4M Grant Approval From Israel Innovation Authority
BioHarvest Sciences Inc (NASDAQ:BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that the Israel Innovation Authority…
-
5 months ago benzinga.com
BioHarvest Sciences Expands Its Joint Sweetener Development Program With Tate & Lyle To Include Multiple Plant-Based Sweetener Molecules
The expanded collaboration builds on the initial agreement signed in 2024 and reflects strong technical progress to date, as well as Tate & Lyle's ambition to equip food and beverage manufacturers…
-
5 months ago benzinga.com
BioHarvest Sciences Affirms FY2026 Sales Guidance of $42.000M-$48.000M vs $44.721M Est
BioHarvest Sciences (NASDAQ:BHST) affirms FY2026 sales outlook from $42.000 million-$48.000 million to $42.000 million-$48.000 million vs $44.721 million estimate.
-
5 months ago benzinga.com
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate
BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 15.38 percent…
-
5 months ago benzinga.com
BioHarvest Sciences' CDMO Division Completes Stage 1 Under Multi-Stage Development Agreement, Establishing Stable Saffron Cell Bank For Potential Nutraceutical And Culinary Applications
- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production of saffron, one of the world's most valuable and…
-
5 months ago benzinga.com
BioHarvest Sciences' CDMO Division Signs $1.2M Stage 2 Contract As Part Of Multi-Stage Development Program For Rare Scent-Producing Plant Used In Global Fragrance Industry
BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that…
-
7 months ago benzinga.com
BioHarvest Sciences Sees FY2026 Sales $42.000M-$48.000M vs $48.432M Est
BioHarvest Sciences (NASDAQ:BHST) sees FY2026 sales of $42.000 million-$48.000 million vs $48.432 million analyst estimate.
-
7 months ago benzinga.com
BioHarvest Sciences Inc. - Common Stock Q4 EPS $(0.10), Inline, Sales $9.100M Miss $9.279M Estimate
BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 41.18 percent increase over losses of $(0.17)…
-
7 months ago benzinga.com
BioHarvest Sciences Announces First Successful Stage 1 Stable Cell Culture Of Scent-Producing Plant
With Stage 1 now completed, BioHarvest is ready to advance to Stage 2, where cells stored in a proprietary cell bank will be propagated in liquid medium to generate significant biomass. Once stage 2…
-
7 months ago benzinga.com
Earnings Scheduled For March 31, 2026
Earnings Scheduled For March 31, 2026
8 months ago benzinga.com
This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
-
8 months ago benzinga.com
Roth Capital Initiates Coverage On BioHarvest Sciences with Buy Rating, Announces Price Target of $10
Roth Capital analyst Sean McGowan initiates coverage on BioHarvest Sciences (NASDAQ:BHST) with a Buy rating and announces Price Target of $10.
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
-
1 year ago benzinga.com
Earnings Scheduled For August 11, 2025
Earnings Scheduled For August 11, 2025